508 related articles for article (PubMed ID: 31830901)
1. Long non-coding RNA MCM3AP-AS1 promotes growth and migration through modulating FOXK1 by sponging miR-138-5p in pancreatic cancer.
Yang M; Sun S; Guo Y; Qin J; Liu G
Mol Med; 2019 Dec; 25(1):55. PubMed ID: 31830901
[TBL] [Abstract][Full Text] [Related]
2. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MCM3AP-AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR-193a-5p/SENP1.
Zhou M; Bian Z; Liu B; Zhang Y; Cao Y; Cui K; Sun S; Li J; Zhang J; Wang X; Li C; Yao S; Yin Y; Fei B; Huang Z
Cancer Med; 2021 Apr; 10(7):2470-2481. PubMed ID: 33686713
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.
Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G
Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335
[TBL] [Abstract][Full Text] [Related]
5. lncRNA MCM3AP-AS1 inhibits the progression of colorectal cancer via the miR-19a-3p/FOXF2 axis.
Dai W; Zeng W; Lee D
J Gene Med; 2021 Mar; 23(3):e3306. PubMed ID: 33450091
[TBL] [Abstract][Full Text] [Related]
6. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis.
Chen Q; Xu H; Zhu J; Feng K; Hu C
Biomed Pharmacother; 2020 Aug; 128():110289. PubMed ID: 32485570
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
Li H; Jiang J
J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells.
Wang H; Xu T; Wu L; Xu HL; Liu RM
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2452-2461. PubMed ID: 32196596
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p.
Shen D; Li J; Tao K; Jiang Y
Bioengineered; 2021 Dec; 12(1):3525-3538. PubMed ID: 34346845
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
Zhang C; Huang J; Lou K; Ouyang H
Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer.
Luo H; Zhang Y; Qin G; Jiang B; Miao L
BMC Cancer; 2021 Jul; 21(1):820. PubMed ID: 34271873
[TBL] [Abstract][Full Text] [Related]
13. Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis.
Li B; Lou G; Zhang J; Cao N; Yu X
BMC Cancer; 2022 Jan; 22(1):124. PubMed ID: 35100978
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
15. YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p/KPNA4 axis.
Li X; Yu M; Yang C
J Cell Biochem; 2020 Mar; 121(3):2258-2267. PubMed ID: 31693222
[TBL] [Abstract][Full Text] [Related]
16. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
Zhang Z; Zhang W; Mao J; Xu Z; Fan M
Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
[TBL] [Abstract][Full Text] [Related]
17. SOX4-activated lncRNA MCM3AP-AS1 aggravates osteoarthritis progression by modulating miR-149-5p/Notch1 signaling.
Xu F; Hu QF; Li J; Shi CJ; Luo JW; Tian WC; Pan LW
Cytokine; 2022 Apr; 152():155805. PubMed ID: 35202986
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA Differentiation Antagonizing Nonprotein Coding RNA (DANCR) Promotes Proliferation and Invasion of Pancreatic Cancer by Sponging miR-214-5p to Regulate E2F2 Expression.
Yao Z; Chen Q; Ni Z; Zhou L; Wang Y; Yang Y; Huang H
Med Sci Monit; 2019 Jun; 25():4544-4552. PubMed ID: 31213582
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of circAPLP2 Inhibits Progression of Colorectal Cancer by Regulating miR-485-5p/FOXK1 Axis.
Liu J; Zhang J; Wang Z; Xi J; Bai L; Zhang Y
Cancer Biother Radiopharm; 2021 Nov; 36(9):737-752. PubMed ID: 32343603
[No Abstract] [Full Text] [Related]
20. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]